phosphatidylcholines has been researched along with isobavachalcone in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (isobavachalcone) | Trials (isobavachalcone) | Recent Studies (post-2010) (isobavachalcone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 95 | 0 | 75 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | isobavachalcone (IC50) |
|---|---|---|---|
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | 0.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Błaszczyk, M; Palko-Łabuz, A; Środa-Pomianek, K; Wesołowska, O | 1 |
1 other study(ies) available for phosphatidylcholines and isobavachalcone
| Article | Year |
|---|---|
Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Binding, Competitive; Cell Line, Tumor; Chalcones; Dogs; Doxorubicin; Drug Combinations; Drug Resistance, Neoplasm; Gene Expression; HT29 Cells; Humans; Inhibitory Concentration 50; Lipid Bilayers; Madin Darby Canine Kidney Cells; Membranes, Artificial; Models, Molecular; Phosphatidylcholines; Plant Extracts; Plants, Medicinal; Protein Binding; Psoralea; Transgenes; Verapamil | 2021 |